Infectious Complications in Multiple Myeloma Patients Receiving Various Antitumor Regimens
A. M. Novikova(Association of Rheumatologists of Russia), Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), G. A. Klyasova(Ministry of Health of the Russian Federation), Т. А. Туполева(Endocrinology Research Center), В. В. Рыжко(Endocrinology Research Center), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Е О Грибанова
Cited by 4
Related Papers
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines
|Journal of Infection|2017|198
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
|Obesity and metabolism|2021|123
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92